PCA3 and posterior cortical atrophy: PCA3, one of the most commonly used urine markers for the prognosis of PCa, has been reported to have a sensitivity of 65%, specificity of 73% in detecting prostate cancer, respectively (13, 14), while AR-V7 positive was detected in a large portion of CRPC.